Nuzenio

Tradingview Sptx

Tradingview Sptx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Seaport Therapeutics reports Q2 2026 net loss $62.6M, $427.3M cash; advances GlyphAllo and GlyphAgo - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMTSeaport Therapeutics, Inc. 2Q 2026: Revenue $0 Net loss $(62.6)M, EPS $(1.78) — 10-Q Summary - TradingViewTradingView · Mon, 03 Aug 2026 11:21:01 GMTSPTX: Net loss widened to $88M in H1 2026 as R&D ramped up; cash runway extends into 2029 - TradingViewTradingView · Mon, 03 Aug 2026 11:13:02 GMTSPTX: Advanced clinical pipeline and strong cash position following $260M IPO, despite higher Q2 losses - TradingViewTradingView · Mon, 03 Aug 2026 11:06:51 GMTSPTX Stock Price and Chart — NASDAQ:SPTX - TradingViewTradingView · Mon, 03 Aug 2026 07:00:00 GMTSeaport Therapeutics, Inc. Revenue Breakdown – NASDAQ:SPTX - TradingViewTradingView · Sat, 01 Aug 2026 05:35:50 GMTSPTX: Oral neuropsychiatric drug candidates advance with strong early data and cash runway into 2029 - TradingViewTradingView · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Mon, 03 Aug 2026 11:23:01 GMTSeaport Therapeutics reports Q2 2026 net loss $62.6M, $427.3M cash; advances GlyphAllo and GlyphAgo - TradingView
Mon, 03 Aug 2026 11:21:01 GMTSeaport Therapeutics, Inc. 2Q 2026: Revenue $0 Net loss $(62.6)M, EPS $(1.78) — 10-Q Summary - TradingView
Mon, 03 Aug 2026 11:13:02 GMTSPTX: Net loss widened to $88M in H1 2026 as R&D ramped up; cash runway extends into 2029 - TradingView
Mon, 03 Aug 2026 11:06:51 GMTSPTX: Advanced clinical pipeline and strong cash position following $260M IPO, despite higher Q2 losses - TradingView
Mon, 03 Aug 2026 07:00:00 GMTSPTX Stock Price and Chart — NASDAQ:SPTX - TradingView
Sat, 01 Aug 2026 05:35:50 GMTSeaport Therapeutics, Inc. Revenue Breakdown – NASDAQ:SPTX - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Sptx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.